Related Experiment Video
Updated: Jul 17, 2025
04:40
Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device
Published on: November 4, 2022
1.1K
Refractory kaposiform lymphangiomatosis relieved by splenectomy
Yuru Lan1, Jiangyuan Zhou1, Tong Qiu1
1Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China.
Frontiers in Pediatrics
|September 4, 2023
Summary
Splenectomy offers a promising treatment for Kaposiform lymphangiomatosis (KLA) when medications fail. This surgical option significantly improved symptoms in patients with this rare lymphatic anomaly.
Area of Science:
- Vascular Anomalies
- Pediatric Surgery
- Hematology
Background:
- Kaposiform lymphangiomatosis (KLA) is a rare, aggressive lymphatic vascular anomaly.
- KLA presents a poor prognosis with limited standard treatment options.
- Drug therapies are common but not always effective, necessitating alternative treatments.
Purpose of the Study:
- To review KLA patient cases treated with splenectomy.
- To explore the potential link between splenectomy and improved KLA prognosis.
- To investigate the underlying mechanisms of KLA treatment response.
Main Methods:
- Retrospective review of 3 KLA patients who underwent splenectomy.
- Analysis of clinical data, laboratory results, and histopathology.
- Immunohistochemical staining for specific markers (CD31, CD34, podoplanin, Prox-1, Ang-2).
Main Results:
- All patients had diffuse KLA lesions involving lungs and spleen.
- Patients presented with thrombocytopenia and low fibrinogen levels.
- Splenectomy led to significant symptom improvement in all cases, with KLA confirmed histopathologically.
Conclusions:
- Splenectomy is a viable therapeutic option for refractory KLA.
- Improved outcomes may relate to angiopoietin 2 (Ang-2) levels and platelet activation.
- Further research into targeted therapies based on molecular findings is warranted.
